New Jersey man alleges manufacturer stalled adding Tepezza hearing damage warnings to the label, even after the FDA determined such injuries could be permanent.
Hearing aids may help reduce strain on the brain from hearing loss, and reduce the risk of cognitive decline or other effects of Parkinson’s.
Tepezza hearing loss lawyers claim counsel representing the drug maker tried to coach a company employee during depositions and interfere with interviews.
Manufacturer argues that nearly all claims presented in the Tepezza hearing loss lawsuits selected for bellwether trials should be dismissed based on federal preemption
Court-ordered mediation sessions will be held every three months, to explore the potential for Tepezza hearing loss settlements in advance of the first trial dates.
Horizon failed to instruct doctors to conduct routine hearing tests on patients to monitor for signs of hearing impairment from Tepezza, lawsuit states.
A series of four Tepezza hearing loss lawsuits will go to trial between March 9, 2026 and August 24, 2026, to help determine the average payout juries may award and promote settlement negotiations
Plaintiffs' proposed Tepezza bellwether schedule would see the first cases go before juries in early 2026, while defendants' plan would not result in a trial until mid-2027
Recalled 3M earmuffs may be defective and noise-reduction features may fail, exposing users to a risk of hearing loss, tinnitus and other ear problems
Judge agreed to delay bellwether trial picks for 60 days, but ordered Horizon Therapeutics to turn over all raw clinical trial data to plaintiffs, who indicate the drug manufacturer's science was flawed.
